Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

Published:2013-01-22 Issue:2 Volume:28 Page:365-368
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Wu Lina¹,Li Li²,Meng Shucong²,Qi Ruizhao³,Mao Zebin¹,Lin Ming²

Affiliation:

1. Department of Biochemistry and Molecular Biology; School of Basic Medical Science; Peking University; Beijing China

2. Department of Cell Biology; School of Basic Medical Science; Peking University; Beijing China

3. The 302nd Military Hospital of Chinese PLA; Beijing China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12043/fullpdf

Reference18 articles.

1. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo;Ensor;Cancer Res.,2002

2. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer;Delage;Int. J. Cancer,2010

3. Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermal carcinogenesis in the mouse;Gonzalez;Cancer Res.,1991

4. In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion;Szlosarek;Clin. Cancer Res.,2006

5. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies;Izzo;J. Clin. Oncol.,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Two-Dimensional Liquid Chromatographic Method for Analysis of Urea Cycle Amino Acids;Molecules;2024-02-02

2. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors;Frontiers in Oncology;2023-11-20

3. Arginine deprivation as a treatment approach targeting cancer cell metabolism and survival: A review of the literature;European Journal of Pharmacology;2023-08

4. PSMD2 contributes to the progression of esophageal squamous cell carcinoma by repressing autophagy;Cell & Bioscience;2023-03-30

5. Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer;Frontiers in Endocrinology;2022-01-26